Related references
Note: Only part of the references are listed.Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
Maria Jose Magraner et al.
NEURORADIOLOGY (2012)
CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis
T. Pirttilä et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
F. G. Joseph et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Association between MRI parameters and the MS severity scale: a 12 year follow-up study
A. Minneboo et al.
MULTIPLE SCLEROSIS (2009)
A multifactorial prognostic index in multiple sclerosis - Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease
Jessica Mandrioli et al.
JOURNAL OF NEUROLOGY (2008)
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
M. Tintore et al.
NEUROLOGY (2008)
Influence of oligoclonal IgM specificity in multiple sclerosis disease course
L. M. Villar et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis:: a 3-year follow-up analysis of the BENEFIT study
Ludwig Kappos et al.
LANCET (2007)
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis
P. Perini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis
LM Villar et al.
ANNALS OF NEUROLOGY (2003)
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
LM Villar et al.
NEUROLOGY (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
G Comi et al.
LANCET (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
